Computational Comparative Study of Tuberculosis Proteomes Using a Model Learned from Signal Peptide Structures by Lai, Jhih-Siang et al.
Computational Comparative Study of Tuberculosis
Proteomes Using a Model Learned from Signal Peptide
Structures
Jhih-Siang Lai, Cheng-Wei Cheng, Ting-Yi Sung*, Wen-Lian Hsu*
Institute of Information Science, Academia Sinica, Taipei, Taiwan
Abstract
Secretome analysis is important in pathogen studies. A fundamental and convenient way to identify secreted proteins is to
first predict signal peptides, which are essential for protein secretion. However, signal peptides are highly complex
functional sequences that are easily confused with transmembrane domains. Such confusion would obviously affect the
discovery of secreted proteins. Transmembrane proteins are important drug targets, but very few transmembrane protein
structures have been determined experimentally; hence, prediction of the structures is essential. In the field of structure
prediction, researchers do not make assumptions about organisms, so there is a need for a general signal peptide
predictor. To improve signal peptide prediction without prior knowledge of the associated organisms, we present a
machine-learning method, called SVMSignal, which uses biochemical properties as features, as well as features acquired
from a novel encoding, to capture biochemical profile patterns for learning the structures of signal peptides directly. We
tested SVMSignal and five popular methods on two benchmark datasets from the SPdb and UniProt/Swiss-Prot databases,
respectively. Although SVMSignal was trained on an old dataset, it performed well, and the results demonstrate that
learning the structures of signal peptides directly is a promising approach. We also utilized SVMSignal to analyze proteomes
in the entire HAMAP microbial database. Finally, we conducted a comparative study of secretome analysis on seven
tuberculosis-related strains selected from the HAMAP database. We identified ten potential secreted proteins, two of which
are drug resistant and four are potential transmembrane proteins. SVMSignal is publicly available at http://bio-cluster.iis.
sinica.edu.tw/SVMSignal. It provides user-friendly interfaces and visualizations, and the prediction results are available for
download.
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Introduction
Signal peptides are short sequences that start from the N-
terminus and control protein secretion. They are related to drug
targets, protein production, and even biomarker discovery [1–4].
Normally, signal peptides in proteins are recognized and cleaved
by their corresponding proteases, and then the cleaved proteins
are secreted [5]. In some cases, however, instead of being cleaved,
the signal peptides form signal anchors, which are a type of
transmembrane protein [6]. Moreover, as shown by Gierasch [7]
signal peptides are interchangeable as well as highly tolerant, i.e.,
they allow some mutations. Thus it is important to identify signal
peptides in proteins.
Proteins targeting to organelles or outside of the cell sometimes
need a cleavable signal peptide. Signal peptide has its systematic
structure, an amino-terminal positively charged region (n-region),
followed by a central, hydrophobic region (h-region), then
followed by a more polar carboxy-terminal region (c-region) [6].
The hydrophobic core of h-region could be recognized by the SRP
(signal recognition particle). C-region usually contains a motif
before the cleavage site that can be cleaved by appropriate
protease. For example, the bacterial signal peptides consist of
positive charge residues, hydrophobic core, and a motif such as
Ala-X-Ala, just before the cleavage site to direct the protein going
through the Sec pathway. The Tat signal peptide also has the
above (n, h, c)-regions structure, particularly having consecutive
arginines in n-region, to direct the protein going through the Tat
pathway. The lipoprotein signal peptide also has the above
structure, and particularly a cysteine follows the cleavage site for
lipid modification.
Modifying the residues of these cleavable signal peptides may
affect protein secretion. For example, the secretion efficiency may
be mediated by hydrophobicity in h-region and charge in n-region
[8,9]. Modification at cleavage site may extend or shorten the
mature protein sequence, and then may slightly alter the protein
structure. Completely removing c-region may yield the signal
peptide uncleaved and form a signal anchor for transmembrane
proteins.
Since the pairwise sequence similarity of signal peptides is
usually low, they cannot be detected simply by sequence alignment
analysis [10]. To predict signal peptides, rules have been devised
for the analysis of signal peptide cleavage sites [11]. Combined the
rules with the signal peptide structure, i.e., (n, h, c)-regions, can
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difficulty with this technique is that signal peptides may be
misclassified as transmembrane domains, and vice versa, because
both regions contain hydrophobic cores, and hydrophobicity is a
key feature of signal peptide prediction methods [6]. Transmem-
brane proteins are important drug targets, but very few
transmembrane protein structures have been determined exper-
imentally. Accurate prediction of transmembrane protein struc-
tures is essential. If the transmembrane domain of a transmem-
brane protein is misclassified as a signal peptide, or vice versa, it
would lead to incorrect transmembrane protein structure predic-
tion and also inaccurate secretion analysis. Several methods have
been developed for signal peptide prediction based on three
domains of a signal peptide structure. For example, SignalP uses
neural networks and hidden Markov models to construct the (n, h,
c)-regions and improve the disambiguation between transmem-
brane proteins and signal peptides [12–14]; and PrediSi exploits a
position weight matrix to predict cleavage sites [15]. Phobius,
which uses a hidden Markov model, was the first predictor to
predict both the topologies of transmembrane proteins and signal
peptides [16]. RPSP is a neural network-based method designed
for proteomic analysis [17]; and Philius uses dynamic Bayesian
networks to model transmembrane protein topology and signal
peptide [18].
Although the structure of (n, h, c)-regions provides good clues
for signal peptide prediction and clearer rules have been defined
for the c-region, the n-region and h-region have ambiguous
boundaries and are diversified in terms of sequences and
organisms. Thus in this paper we present a machine learning
approach based on support vector machines (SVMs), called
SVMSignal, to learn the structures of signal peptides and classify
signal peptides from transmembrane proteins. SVMSignal uses
basic biochemical profiles as features and also defines a novel
feature to capture the inter-profile relationships that describe the
structural properties of signal sequences.
We compared the performance of SVMSignal with that of
existing methods on two benchmark datasets, the signal peptide
database SPdb [19] and a hybrid dataset compiled from UniProt/
Swiss-Prot [20] and PDBTM [21] (Protein Data Bank of
Transmembrane Proteins), a transmembrane protein structure
database. We used experimentally determined signal peptide
sequences from SPdb and UniProt/Swiss-Prot as the signal
peptide benchmark to demonstrate the sensitivities of various
signal peptide predictors. In order to evaluate the specificities and
classification abilities of different predictors, we collected soluble
proteins from UniProt/Swiss-Prot and transmembrane proteins
from both UniProt/Swiss-Prot and PDBTM as benchmark. Our
method SVMSignal achieved good performance on the bench-
mark datasets.
Signal peptides are crucial to protein secretion, and secretome
analysis is important in pathogen studies because it has been
shown that some hosts are affected by proteins secreted from
bacteria [22,23]. There are at least six known secretion systems,
i.e., Types I to VI, as well as the Sec and Tat pathways in Gram-
negative bacteria [5]. Signal peptides are not responsible for all of
the secretions. Although proteins containing signal peptides (called
signal peptide proteins hereafter) cannot characterize the full
secretome, it is still necessary to use sequence information to
discover potential secreted proteins for further research [24,25].
HAMAP (High-quality Automated and Manual Annotation of
microbial Proteomes) microbial database [26] provides 1292
curated microbial proteomes and description of microbial
pathogens, and proteomes in the database are also integrated
with UniProt/Swiss-Prot. It is considered as an important
database for pathogen studies [27,28]. We applied our method
to HAMAP to predict signal peptides in proteomes so that signal
peptide-dependent secreted proteins could be identified.
From the pathogens recorded in the HAMAP database, we
selected tuberculosis to conduct secretome analysis because it is a
historical human interactive pathogen, and it is still difficult to
treat in some cases, e.g., drug-resistant strains and immunocom-
promised HIV patients. Recently, Walzl et al. presented a review
paper that suggests using an ‘‘omics’’ approach to find potential
immunological biomarkers of tuberculosis [29]. To this end, we
made an in-depth analysis of proteins with signal peptides in
Mycobacterium tuberculosis and Mycobacterium bovis, which can
cause tuberculosis in humans and cattle, respectively. It is also
possible for Mycobacterium bovis to infect humans via certain
foods, such as unpasteurized milk. We selected seven strains from
the two pathogens for study, including virulent strains, attenuated
strain, and drug-resistant strains. Due to their close lineage, the
comparative study of signal peptide-dependent secreted proteins
belonging to different strains can provide clues about the
tuberculosis mechanism, virulence factors or biomarkers. The
signal peptide prediction results of the entire HAMAP database
are provided for further research.
Results
Performance evaluation of SVMSignal
We compared the performance of SVMSignal with that of five
existing predictors, namely, Phobius [16], RPSP [17], Philius [18],
SignalP [12–14] (specifically SignalP 3.0), and PrediSi [15]. Each
of the last two predictors provides three models specifically
developed for Gram-positive bacteria, Gram-negative bacteria and
eukaryotes. We included all of the models in the performance
evaluation.
To avoid over-estimating SVMSignal’s performance in com-
parison with the other predictors, we used the original Phobius
2004 dataset to train our model. We tested all of the methods on
the two benchmark datasets mentioned earlier, i.e., the signal
peptide database SPdb [19] (called the SPDB dataset hereafter),
and a hybrid dataset compiled from UniProt/Swiss-Prot [20] and
PDBTM [21] in 2010. Note that we filtered each of the
benchmark datasets by removing sequences with over 30%
similarity to sequences in the training dataset and within the
dataset itself. Both datasets were decomposed by organism into
mixed, eukaryotes, and bacteria for analysis; archaea and viruses
were omitted because there was insufficient data for them. We
further decomposed the second benchmark dataset into SP
(proteins with signal peptides), TM (proteins with transmembrane
domains only), and G (proteins without signal peptides or
transmembrane domains) datasets. Note that the SP dataset
contains very few proteins with both transmembrane domains and
signal peptides. All of the above datasets are provided in the
Supporting Information (Dataset S1).
To evaluate the performance of various predictors, we define
sequences with signal peptides as positive (P) data, and those
without signal peptides as negative data (N). We use the following
metrics to evaluate the performance sensitivity~TP= TPzFN ðÞ ,
specificity~TN= TNzFP ðÞ and accuracy~ TNzTP ðÞ = TPz ð
FPzTNzFNÞ, where T and F denote ‘‘true’’ and ‘‘false’’,
respectively. Accuracy alone is insufficient to reflect a global
perspective of good sensitivity in signal peptides and speci-
ficity in non-signal peptides, especially specificity in transmem-
brane domains required by a good predictor, due to the data
imbalance. Therefore, to evaluate the performance from a
global perspective, we use MCC (Matthew’s correlation coe-
Tuberculosis Analysis by Signal Peptide Prediction
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ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPzFP ðÞ TPzFN ðÞ TNzFN ðÞ TNzFP ðÞ
p   
.
Evaluating SVMSignal’s ability to disambiguate proteins
with and without signal peptides
Predictors sometimes confuse signal peptides with transmem-
brane domains due to hydrophobic composition. We evaluated
SVMSignal’s ability to classify signal peptides and non-signal
peptides, i.e., to disambiguate the SP dataset from the TM and
TM+G datasets, denoted by SP/TM and SP/(TM+G), respec-
tively. The MCCs of SVMSignal and the other predictors on
different organism datasets are detailed in Table 1. SVMSignal
outperformed the other predictors on the mixed organisms and
eukaryotes in SP/TM and SP/(TM+G), except on the eukaryotes
in SP/TM as the second best, with 2.24% slightly worse than the
best SignalP model. Notably, in the mixed organisms, SVMSignal
outperformed the second best predictor by 0.54% and 3.31% on
SP/TM and SP/(TM+G), respectively. It also achieved the second
best performance on the bacteria in SP/TM and the third best
performance on the bacteria in SP/(TM+G).
As shown in Table 2, the accuracy of SVMSignal’s classification
with respect to different organisms ranged from 90% to 92% for
SP/TM and exceeded 96% for SP/(TM+G). SVMSignal achieved
the best accuracy in classifying SP/(TM+G) of the mixed
organisms and eukaryote datasets. It achieved the second best
accuracy in SP/TM of mixed organisms and SP/(TM+G) of
bacteria with at most 0.4% difference to the best accuracy, and the
third best accuracy in the remaining datasets with at most 2% gap
from the best accuracy.
Sensitivity and Specificity of SVMSignal’s predictions on
the signal peptide benchmark datasets
The sensitivities of SVMSignal and the other predictors on the
signal peptide benchmark datasets, SPDB and SP, are shown in
Table 3. Although SVMSignal was trained on an old dataset and it
was not trained on different organisms, it performed well
compared to most of the predictors. As SignalP was trained
specifically on different organisms, reflected by variations in the
sensitivities of different models, SVMSignal performed slightly
inferior to SignalP by at most 0.92% on the mixed organism
datasets, at most 2.88 on the eukaryotes datasets, and at most
2.58% on the bacteria datasets.
We compared the specificities of SVMSignal and the other
predictors on proteins without signal peptides in the TM and
TM+G datasets. As shown in Table 4, for the TM classification,
SVMSignal achieved the best performance on the mixed organism
and eukaryote datasets, and was only outperformed by Philius on
the bacteria dataset. For the TM+G classification, SVMSignal’s
performance differed from the best performance by at most
1.48%; however, on the three organism datasets of TM+G, it
achieved over 97% specificity, which was very close to the
specificity achieved by SignalP.
Application of SVMSignal to tuberculosis pathogen study
We applied signal peptide prediction to secretome analysis in
tuberculosis pathogen since tuberculosis is a well-known infectious
disease that can be fatal. Notably, signal peptides of tuberculosis
proteomes are related to its virulence [30–32]. Since very few
proteins of tuberculosis strains have been annotated, we used
SVMSignal to predict signal peptides and performed a compar-
ative study of the predicted signal peptide proteins of tuberculosis
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would be worth further investigation.
For our study, we selected seven interesting strains related to
tuberculosis: four strains from Mycobacterium tuberculosis and
three strains from Mycobacterium bovis in the HAMAP database
[26]. Specifically, the four strains of Mycobacterium tuberculosis
are MYCTU, MYCTA, MYCTF, MYCTK, where MYCTU is
the virulent H37Rv strain, MYCTA is the highly attenuated
H37Ra strain, MYCTF is the virulent strain family 11, and
MYCTK is the drug resistant KZN 1435 strain. The other three
strains are one strain of Mycobacterium bovis coded as MYCBO,
and two strains of Mycobacterium bovis bacillus Calmette–Gue ´rin
(BCG) coded as MYCBP and MYCBT, respectively. MYCBP is a
BCG strain developed at the Pasteur Institute in Paris and
MYCBT is another BCG strain used in Japan. In the following
discussion, we use the species code instead of the full name to
represent each of the strains and the UniProt/Swiss-Prot accession
number to represent a protein.
To identify signal peptide proteins that characterize each
pathogen strain, we first applied SVMSignal to the seven
proteomes of the strains, and we were only interested in the
predicted signal peptide proteins. The statistics of the signal peptide
proteins in the seven proteomes, i.e., four strains from Mycobac-
terium tuberculosis and three strains from Mycobacterium bovis,
are shown in Table 5. There are 334 to 345 signal peptide
proteins, i.e., 8.33% to 8.73% of the total proteins, in each
proteome. Signal peptide proteins predicted to contain transmem-
brane domains account for 1.59% to 1.88% of the proteins in a
proteome. Furthermore, the number of multi-spanning trans-
membrane proteins is double that of single-spanning transmem-
brane proteins. The average length of signal peptides is 28 to 29
residues, and the average length of the entire bacteria pathogen in
the HAMAP database is 26.02. See the Discussion section and
Supporting Information (Datasets S2 and S3) for more details.
Comparative Study on the selected tuberculosis strains
To compare the seven tuberculosis strains, we used CD-HIT
[33] and the 30% similarity threshold to cluster the signal peptide
proteins by their sequences with signal peptides removed, i.e., their
secreted sequences. Since secreted proteins affect their hosts and
are of interest to us, we used them to cluster the corresponding
signal peptide proteins. The process generated 313 clusters, of
which 10 contained only one protein, whose similarity to all the
other sequences was less than 30%. We call such a signal peptide
protein a unique protein because it does not occur in any of the other
six proteomes. Table 6 lists all the unique proteins found in the
seven proteomes. MYCBP and MYCBT do not contain any
unique proteins, while each of the other five strains has at least one
unique protein. Interestingly, the human tuberculosis drug
resistant strain MYCTK has six unique proteins. Furthermore,
we removed signal peptides from the unique proteins and used
TMHMM [34,35] to predict whether their secreted sequences
contain transmembrane domains. Four of the unique proteins,
O06239, A5WU15, C6DWG6 and Q7U0W0, were predicted as
multi-spanning transmembrane proteins and also annotated as
transmembrane proteins in the UniProt/Swiss-Prot database.
Next, for each unique protein, we used BLAST to search
against the seven proteomes for similar proteins and the results are
shown in Table 6. Note that the homologous protein of each
unique protein is not signal peptide protein. The alignment results
of the homologous protein pairs are provided in Supporting
Information (Text S1). Six of the homologous protein pairs share a
very high sequence similarity (over 95%), namely, pairs O06239/
C6DPS4 (97.87%), A5U3R8/O07733 (95.54%), A5WU15/
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O06296 (98.55%), and Q7U0W0/C1ALY5 (99.72%). Another
three pairs of proteins share a sequence similarity higher than
60%, i.e., C6DUE9/O06291 (68.56%), C6DWG6/O05916
(61.07%), and C6DTY5/A5TZZ2 (79.86%). We examined all of
the protein pairs and distinguished two cases of homologous
proteins in comparison with their corresponding unique proteins.
In the first case, some N-terminal residues were missing, as well as
in the second case additional N-terminal residues were contained,
thereby disrupting the structure of signal peptides.
Specifically, the first case of homologous proteins includes
O53355, C6DPS4, and O06296. Because some residues are
missing, the n-regions before the Ile, Leucine, and Valine
hydrophobic residues are shorter. Interestingly, O53355 in
MYCTU is a homolog of the unique protein C6DL40 in
MYCTK. Moreover, it is annotated as a high-confidence drug
target in the MYCTU strain without signal peptide annotation or
prediction. In contrast, the unique protein C6DL40 has more N-
terminal residues, including four positive residues of arginine,
which extend the n-region. This probably accounts for the signal
peptide structure. The pair comprised of C6DPS4 in MYCTK
and the unique protein O06239 in MYCTU is also interesting
because O06239 is annotated as a multi-spanning transmembrane
protein and a high-confidence drug target in UniProt. However,
UniProt/Swiss-Prot does not annotate O06239 as a signal peptide
protein, but SVMSignal indicates that a signal peptide exists.
The second case of homologous proteins includes O07733,
P72030, O06291, O05916, and A5TZZ2. Among them, O07733,
P72030 and A5TZZ2 have additional charge-intensive regions at
the N-terminus, but they do not have h-region followed. The other
two proteins, O06291 and O05916, have over 150 additional
residues at the N-terminus, and their remaining subsequences are
identical to their corresponding unique proteins. Although
SVMSignal predicts that O05916 may have cleavage sites, the
protein is not predicted as a signal peptide protein.
O06239 (Rv2136c) vs. C6DPS4 (TBMG_01845). The
unique signal peptide protein O06239 of MYCTU is encoded
by Rv2136c.The Rv2136c gene encodes a putative homologue of
E. coli’s UppP [36]. Since Mycobacterium tuberculosis (Mtb) has
the ability to block phagosome acidification and thereby
contributing to resist the drug bacitracin [37,38], researchers are
interested in discovering the genes responsible for Mtb’s acid
resistance. Vandal et al. used transposon mutagenesis to discover
genes for acid resistance, and then measuring the intrabacteria pH
Table 5. Basic statistics in the selected seven proteomes of Mycobacterium tuberculosis (*) and Mycobacterium bovis (**).
code name # proteins # SP proteins (%)
SP mean
length
# SPTM
proteins (%) # SPTM single
# SPTM
multi
MYCTU *Mycobacterium tuberculosis 3950 345 (8.73%) 28.4 71 (1.80%) 23 48
MYCTA *strain ATCC 25177/H37Ra 3990 345 (8.65%) 28.2 69 (1.73%) 22 47
MYCTF *strain F11 3905 334 (8.55%) 29.0 66 (1.69%) 22 44
MYCTK *strain KZN 1435/MDR 4024 335 (8.33%) 28.7 64 (1.59%) 22 42
MYCBO **Mycobacterium bovis 3910 334 (8.54%) 28.2 72 (1.84%) 22 50
MYCBP **strain BCG/Pasteur 1173P2 3891 336 (8.64%) 28.1 73 (1.88%) 25 48
MYCBT **strain BCG/Tokyo 172/ATCC 35737/TMC 1019 3906 340 (8.70%) 28.2 73 (1.87%) 25 48
doi:10.1371/journal.pone.0035018.t005
Table 6. List of unique proteins and their similar non-signal peptide proteins.
Unique proteins Similar proteins
Species ID gene
TMHMM
results
Seq.
length(after
cleaved) Species ID gene
SVMSignal
results
Seq.
length
type (similar
protein)
MYCTU O06239 Rv2136c multi-pass TM 282 (261) MYCTK C6DPS4 TBMG_01845 non SP 276 residues missing
MYCTA A5U3R8 MRA_1910 non TM 343(283) MYCTU O07733 Rv1899c non SP 359 residues addition
MYCTF A5WU15 TBFG_13829 multi-pass TM 1082(1051) MYCTU P72030 Rv3795 non SP 1098 residues addition
MYCTK C6DL40 TBMG_03351 non TM 481(457) MYCTU O53355 Rv3303c non SP 493 residues missing
MYCTK C6DUE9 TBMG_02759 non TM 362(329) MYCTU O06291 Rv1223 non SP 528 residues addition
MYCTK C6DWG6 TBMG_03065 multi-pass TM 262(239) MYCTU O05916 Rv0924c non SP 428 residues addition
MYCTK C6DSD8 TBMG_00349 non TM 138(120) MYCTU O06296 Rv0345 non SP 136 residues missing
MYCTK C6DTY5 TBMG_00617 non TM 111(89) MYCTA A5TZZ2 MRA_0618 non SP 139 residues addition
MYCTK C6DQS5 TBMG_03974 non TM 53(28) - - -
MYCBO Q7U0W0 Mb1023 multi-pass TM 358(330) MYCBT C1ALY5 JTY_1023 non SP 358 residue
replacement
MYCBP - - - - - - -
MYCBT - - - - - - - -
doi:10.1371/journal.pone.0035018.t006
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and Rv3671c as candidates because the mutation in these two
genes would cause the strain sensitive to acid. However, they only
performed further analysis on Rv3671c because mutant
phenotypes of Rv2136c did not revert while the wild-type allele
‘‘in trans’’ was given. Later, Darby et al. deleted the Rv2136c gene
in the H37Rv strain, but could not obtain any phenotype in the
Rv2136c transposon mutant strain mentioned in Vandal et al.’s
experiment [39]. It is mentioned in the paper that they started
sequencing for the Rv2136c transposon mutant strain to verify
whether acid resistance is from mutated Rv2136c or other
mutated genes.
In our study, the protein O06239 contains its similar non-signal
peptide protein C6DPS4 of MYCTK as a long subsequence and
has additional 6 amino acids ‘‘MTAAPA’’ starting from the N-
terminus. But these two proteins are predicted by our predictor to
have dramatically different prediction results, one having signal
peptide and the other none. The additional amino acids show
strong amphiphilicity and the secondary structure predictor JPred
3 predicted that there is a highly probable helix structure [40].
Therefore, the N-terminal segment of O06239 may very likely
form an amphipathic helix.
Furthermore, we also noticed that the Rv2136c encoded
proteins have different sequence lengths, for example,
NP_216652.1 (276 aa), CAB08657.1 (276 aa), O06239.2
(282 aa). These sequences are reported to have length differing
at six amino acids, and such finding on Rv2136c encoded proteins
seems to be controversial. Notably, the homologous proteins
O06239 and C6DPS4 have lengths of 282 and 276, respectively.
As Rv2136c encoded proteins are reported to have different
lengths, the sequence of Rv2136c encoded proteins need to be
further verified.
Furthermore, O06239 is a predicted membrane protein
containing five transmembrane domains as annotated in Uni-
prot/Swiss-Prot and is predicted by SVMSignal to have an
extensively cleavable region. If the longer sequence indeed
contains a cleavable signal peptide, then this transmembrane
protein will be secreted to elsewhere or remain in membrane after
signal peptide cleaved. If the correct sequence is the short version,
then the protein will not be secreted and forms a transmembrane
protein with an N-terminal amphipathic helix. In summary, the
first 100 amino acids of O06239 and C6DPS4 are different and
thus result in different signal peptide prediction results. Moreover,
the Rv2136c transposon mutant strain of H37Rv strain is acid
resistant same as Rv3671c; however, the Rv2136c knockout strain
is not sensitive to acid. Is this phenomenon related to whether the
existence of signal peptide in the Rv2136c encoded sequence? The
sequence of Rv2136c encoded protein needs to be further
clarified.
A5U3R8 (MRA_1910) vs. O07733 (Rv1899c). The non-
signal peptide protein O07733 of MYCTU encoded by the gene
Rv1899c was determined as a unique protein in Mycobacterium
bovis BCG strain when compared with H37Rv, which was
confirmed by 2-DE and mass spectrometry [41]. It is also
suggested that this protein may be related to virulence attenuation
[41].
Herrmann et al. [42] studied post-translationally modification,
specifically glycosylation, of Mycobacterium tuberculosis proteins.
They considered protein of Rv1899c as a candidate for O-
glycosylation lipoprotein; however, its glycosylation was not
confirmed in their experiment. Later, this protein was annotated
as one of H37Rv membrane proteins as determined by one-
dimensional SDS gels with LC-MS (liquid chromatography-mass
spectrometry) [43]. Interestingly and contradictorily, this protein
was annotated as exported lipoprotein by 2-DE combined with
MALDI-TOF MS and LC-MS/MS [44]. Note that O07733 is
annotated as uncharacterized protein, but annotated in GO as
plasma membrane and extracellular region. It becomes a question
worth of further investigation whether O07733 encoded by
Rv1899c is localized at the membrane or exported extracellular.
The homologous proteins A5U3R8 (MRA_1910) and O07733
(Rv1899c) have 343 amino acids and 359 amino acids,
respectively. O07733 contains A5U3R8 as a subsequence and
has additional 16 amino acids at the N-terminus. Both of them
have only one weak hydrophobic core near the N-terminus. If
O07733 is a membrane protein, the only hydrophobic region
would be the membrane core. Moreover, this hydrophobic region
may form an amphipathic helix because high amphiphilicity
around the region are observed from SVMSignal’s visualization of
biochemical profiles and the secondary structure predictor JPred 3
[40] predicts it as a helix.
Furthermore, the protein sequence of O07733 provided by
UniProt/Swiss-Prot is slightly different from the protein sequence
annotated for the gene Rv1899c (CAB10035.1) in the GenBank,
the former 359 amino acids and the latter 343 amino acids. It is
worthwhile to verify the sequence of Rv1899c protein and
determine the existence of signal peptide therein. Note that
NetOGlyc [45] predicts several glycosylation sites on O07733, and
proteins with signal peptide are more probable to have O-
glycosylation. If SVMSignal’s prediction on O07733 as non-signal
peptide protein is correct, it may explain why the Rv1899c protein
did not occur in the experiment reported in [42] and supports the
experiment in [43] that Rv1899c is a membrane protein. Its
homologous protein A5U3R8 of the attenuated strain MYCTA is
predicted to contain signal peptide by SVMSignal, and the
existence of signal peptide may support glycosylation.
A5WU15 (TBFG_13829) vs. P72030 (Rv3795). The protein
P72030, also called EmbB protein, of MYCTU encoded by gene
Rv3795 was a drug target. The first line drug Ethambutol (EMB)
can inhibit three proteins EmbA, EmbB, and EmbC in
tuberculosis. Ethambutol targeted proteins, i.e., Emb proteins,
are critical to synthesis arabinogalactan which is involved in cell
wall. The mutation of the embB gene can be observed in
Ethambutol-resistant strain [46]. Genetic polymorphisms of embB
can also be observed in several drug-resistance strains [47].
Though the structures of tuberculosis Emb membrane proteins
have not been solved, the C-terminal hydrophilic domain was
solved in 2011, and the finding supports the suggestion that Emb
proteins function as dimers, the combination of EmbC/EmbC and
EmbA/EmbB [48].
The protein A5WU15 of MYCTF is identical to P72030 except
lack of the first 16 amino acids at the N-terminus. SVMSignal
predicted A5WU15 as signal peptide protein due to its deletion of
the 16 amino acids, making the n-region suitable for forming
signal peptide. If A5WU15 really contains signal peptide, the
cleaved sequence will somewhat affect the structure of EmbB
through removing the first transmembrane domain and the
cleaved positive residues may also affect topology.
C6DL40 (TBMG_03351) vs. O53355 (Rv3303c). The
protein O53355, named LpdA, of MYCYU is encoded by the
Rv3303c gene. The LpdA had been thought as a probable Mtb’s
dehydrogenases; however, it was verified as a NAD(P)H quinone
reductase [49]. The protein of Rv3303c was also supposed to
contribute to the virulence because the NAD(P)H quinone
reductase may remove reactive oxygene [50]. Using qRT-PCR
to compare Rv3303c between H37Rv strain and the attenuated
H37Ra strain, the result shows that the lpdA transcript was rarely
detected in the H37Ra strain, but up-regulated significantly in the
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may increase Mtb’s ability against oxidative stress.
The protein structure of O53355 was solved in 2004 [49] and
deposited in Protein Data Bank as 1XDI. The N-terminal region
forms a part of the structure, and thus it is confirmed that this
protein does not have a cleavable signal peptide. It is consistent
with the prediction result of SVMSignal, which predicted O53355
having no signal peptide though containing an extensively
cleavage region.
The protein O53355 and its homolog in the KZN 1435 strain,
i.e., C6DL40 of MYCTK, share 471 amino acids in common.
O53355 has additional 22 amino acids at C-terminus, and
C6DL40 has 10 additional amino acids of ‘‘HRRRARLWAV’’ at
the N-terminus, extending the moderate hydrophobic region and
forming a possible signal peptide by the possible n-region of four
arginines. If the sequence of C6DL40 is correct and the signal
peptide exists, then we can suppose that LpdA of the KZN 1435
strain will be very likely secreted out and thus increase the ability
against oxidative stress.
Moreover, in the sequence alignment of disulfide reductases
including LpdA, only a motif ‘‘GGGPAG’’ near the N-terminus is
observed and lies in the predicted signal peptide domain of KZN
1435 strain. Since the possible interaction residues R (245), S
(213), and Q (214) of the Rv3303c protein do not lie in the signal
peptide domain, cleaving signal peptide may not affect the
function of quinone reductase [49].
C6DUE9 (TBMG_02759) vs. O06291 (Rv1223). The
Rv1223 gene encodes the protein HtrA1 in Mtb, i.e., O06291,
which was reported as a single-spanning transmembrane protein
[32,52,53]. Since this protein has only one hydrophobic region,
which forms a transmembrane domain, it is consistent with
SVMSignal’s prediction that there is no cleavable N-terminal
signal peptide.
The HtrA family proteins in Mtb include HtrA1 (encoded by
Rv1223), HtrA2 (Rv0983) and HtrA3 (Rv0125); however, only
HtrA2’s structure has been determined at 2.0 A ˚, i.e., 2Z9I in the
Protein Data Bank [54]. It was proved that HtrA2 of Mtb is
related to virulence since deletion of the Rv0983 gene in the
mouse model extends the survival [54]. However, the knockout of
htrA1 from H37Rv strain cannot obtain generation, and thus
htrA1 is supposed to be an essential protein in Mtb [54].
Though HtrA1 of the H37Rv stain (O06291) is different from
HtrA1 (Q92743) in human, but the SPD (serine protease domain)
and PDZ (protease domain z) domains in this two species are still
conserved as these two domains in HtrA proteins are conserved
from bacteria to mammalian [55,56].
Interestingly, human HtrA1 which contains an insulin-like
growth factor binding domain is suggested to have signal peptide,
and then secreted out [55]. SVMSignal predicted the only
hydrophobic region of human HtrA1 as signal peptide h-region,
and also supported this argument.
In comparison with O06291, the HtrA1 sequence of KZN 1435
strain simply lacks the first 166 residues at the N-terminus, thus
move the only hydrophobic region and two positive charge
residues forward to an appropriate position for forming a signal
peptide. If the sequence of KZN 1435 strain is correct and signal
peptide exists, the HtrA1 of KZN 1435 strain may be secreted out.
Moreover, some bacteria, e.g., helicobacter pylori, secrete their
HtrA to extracellular, thereby increasing their virulence [55].
Since the sequence of the gene TBMG_02759 recorded in the
GeneBank does not start from the standard start codon, it is worth
of further investigation to verify the HtrA1 sequence of KZN 1435
strain and its possibility of having a signal peptide.
C6DWG6 (TBMG_03065) vs. O05916 (Rv0924c). The
Rv0924c encodes the MntH protein, i.e., O05916, in the Mtb
H37Rv strain. The tuberculosis MntH is an orthologue of the
Nramp protein (natural resistance associated macrophage protein),
which mediates the divalent cation transportation. The pathogen
manganese transporter may compete with the host. If a host has
defects Nramp1, then the host is inclined to be infected. If Nramp
transporter of a pathogen gets mutation, then virulence is
attenuated. The Nramp proteins are conserved from bacteria to
mammalian and the mutation have been shown to attenuate the
virulence [57].
The protein of Rv0924c was initially thought to be a pH-
dependent divalent cation transporter [58]. Later it was reported
that the mntH knockout in the mouse model did not influence the
virulence [59,60]. However, Papp-Wallace and Maguire [57]
suggested that the above conclusion is not yet definite and thought
that there may be some other proteins, .e.g., sitABCD, that might
compensate the loss of mntH [57]. The MntH protein in the Mtb
H37Rv strain is a multi-spanning transmembrane protein, since
the orthologue MntH protein of E. coli was determined as an
eleven transmembrane-segment protein [61]. The difference of
MntH sequences between KZN 1435 strain and H37Rv strain is
that C6DWG6 lacks the first 166 residues from the N-terminus in
O05916. If the MntH sequence of KZN 1435 strain is correct,
then the structure of this transmembrane protein is definitely
different from that of H37Rv, because of lacking at least four
transmembrane domains. Additionally, if the signal peptide truly
exists, the first hydrophobic region will further be cleaved and
affect the structure, the topology of the MntH needs to be
examined again.
Discussion
Using cleavage site information to predict signal
peptides
SVMSignal first predicts the potential cleavage sites of a
sequence and then predicts the signal peptide sequence. If we
consider sequences that possess potential cleavage sites as signal
peptides, the naı ¨ve predictor denoted as ‘‘Cleavable’’ in Table 3
achieves nearly perfect sensitivity on the benchmark SPDB and SP
datasets, irrespective of the type of organism. It seems that the
information in signal peptide cleavage sites can be learned easily;
however, Cleavable predicted several false-positive signal peptides,
and also failed to classify transmembrane proteins and globular
proteins with poor MCCs and specificities, as shown in Table 1
and Table 4, respectively. The above observation implies that
cleavage site information may be easy to learn, but it is not
sufficient to characterize a signal peptide. We believe that
including the structural information of signal peptides in the
Cleavable predictor could improve signal peptide prediction
significantly, as evidenced by SVMSignal’s high sensitivity,
specificity, and MCC on the benchmark datasets. In particular,
the classification was improved from the Cleavable predictor by
over 50% in MCC. This finding implies that learning signal
peptide structures is an effective modeling approach.
Large-scale signal peptide analysis of the HAMAP
database
Bacteria are a major type of human pathogen, and their
secreted proteins often affect hosts. Since the annotations of
microbial proteomes in the UniProt/Swiss-Prot database are
incomplete, we conducted a large-scale secreted protein analysis of
the HAMAP database. We applied SVMSignal to the HAMAP
database (release Feb 2011), which contains 91 archaea, 1130
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proteins, and then determined the secreted proteins accordingly.
SVMSignal’s prediction results on the entire HAMAP database
are provided in Supplementary Data at http://bio-cluster.iis.
sinica.edu.tw/SVMSignal. Here, we consider some general
statistics, which are detailed in Table S1. First, the average
percentage of signal peptide proteins in each proteome is 8.13% in
the archaea, 13.34% in the bacteria, and 10.07% in the
eukaryotes. Second, in the archaea, Halalkalicoccus jeotgali (strain
DSM 18796/CECT 7217/JCM 14584/KCTC 4019/B3) has the
lowest percentage of signal peptide proteins (4.63%), and
Methanoplanus petrolearius (strain DSM 11571/OCM 486/
SEBR 4847) has the highest percentage (14.32%). In the bacteria,
Zinderia insecticola (strain CARI) has 0%, i.e., no signal peptide
proteins, and Bdellovibrio bacteriovorus has the highest percent-
age (32.51%). In the eukaryotes, Hemiselmis andersenii has the
lowest percentage (0.80%), and Pediculus humanus subsp. corporis
has the highest percentage (26.76%.) Finally, the average length of
signal peptides is 26.56 residues in the archaea, 26.02 residues in
the bacteria, and 23.41 residues in the eukaryota.
Transmembrane proteins with signal peptides in HAMAP
proteomes
We also examined transmembrane proteins with signal peptides
in all microbial proteomes of HAMAP because some crystallized
transmembrane proteins contain signal peptides that are easily
confused with transmembrane domains. We removed signal
peptides from the proteins and used TMHMM [34,35] to predict
whether the cleaved proteins contained transmembrane domains.
The average percentage of transmembrane proteins with signal
peptides in the archaea, bacteria and eukaryotes are 3.14%, 2.62%
and 2.10%, respectively. In the archaea, Methanosphaera
stadtmanae (strain DSM 3091) has the lowest percentage
(1.37%), and Aciduliprofundum boonei (strain DSM 19572/
T469) has the highest percentage (4.74%). In the bacteria,
Carsonella ruddii (strain PV) and Zinderia insecticola (strain
CARI) have 0% and Arcobacter nitrofigilis (strain ATCC 33309/
DSM 7299/LMG 7604/NCTC 12251/CI) has the highest
percentage (5.76%). In the eukaryotes, Hemiselmis andersenii
has 0%, and Caenorhabditis elegans has the highest percentage
(4.62%).
Web service
SVMSignal provides a web service that accepts queries with up
to 10,000 sequences in FASTA format. As well as the prediction
results, SVMSignal provides the calculated biochemical proper-
ties, including the free energy, polarity, average volume and
charge index of each residue. The properties are presented in a
compact profile graph for visualization to help users examine
potential signal peptide structures, such as the n-region, h-region,
and c-region. Users can download all the information in the first
100 residues, including predictions in FASTA format, all the
profile values in tab-delimited text format, and the graphs of the
profiles.
Materials and Methods
SVMSignal-a hierarchical SVM-based predictor
SVMSignal performs signal peptide prediction in two stages
using support vector machines (SVMs) as classifiers, as illustrated
in Figure 1. It predicts signal peptides from the first 100 residues of
each protein sequence. The first SVM classifies every residue into
around the cleavage site, denoted by ‘‘C’’, or outside the cleavage
site, denoted by ‘‘L.’’ Since protein sequences containing signal
peptides have cleavage sites, the results from the first classifier can
help the user determine whether a protein sequence contains a
signal peptide. The second classifier integrates the predictions of
the first classifier and other features to classify each residue into the
signal peptide region denoted by ‘‘s’’ or the non-signal peptide
region denoted by ‘‘L.’’ Note that the last predicted residue of the
signal peptide is denoted by ‘‘C.’’ If a protein sequence does not
contain any signal peptides, all of the 100 residues will be assigned
the label ‘‘L’’.
More specifically, the first classifier is a residue-wise predictor.
Given a protein sequence, the residue to be predicted is centered
in a window of length 17. The features derived from a 17-mer
sequence for prediction include: (i) position-specific free energy of
transmembrane helix insertion [62] to describe the hydrophobic
core, called free energy for convenience; (ii) amphiphilicity [63];
(iii) charge index [64]; (iv) polarity [65]; (v) residue volume index
[66], and (vi) amino acid composition. For the first and last eight
residues in the first classifier, we use small values to complete the
columns corresponding to non-existing residues. The second
classifier is a chain-wise predictor that uses the following features:
(i) the prediction results from the first classifier; (ii) the first five
feature profiles with a dimension of 100 used in the first predictor;
and (iii) a novel nonlinear pattern feature that captures the
relationships between any two of the five feature profiles, e.g., the
sequence distance between positively charged residues and the
hydrophobic region. All of the features are normalized to a [0, 1]
closed interval.
Biochemical features
The five features used in the both predictors are described
below. The free energy profile, amphiphilicity profile and polarity
profile are normalized, respectively, by the sigmoidal functions
given by 1{1= 1ze{energy ðÞ , 1{1= 1zeam ðÞ and
1{1= 1ze{po ðÞ , where ‘‘energy’’ denotes the free energy of
transmembrane helix insertion estimated by Hessa et al.’s method
[62]; ‘‘am’’ denotes the amphiphilicity derived by Mitaku et al.’s
method [63]; and ‘‘po’’ denotes the mean residue polarity
calculated by Radzicka and Wolfenden’s method [65]. The
charge profile is obtained by defining positively charged residues
as 1, neutral residues as 0.5, and negatively charged residues as 0
based on the index used by Klein et al. [64]. The volume profile is
used by Pontius et al. [66] and normalized by dividing the
maximum volume value 237.2.
To determine the amino acid composition of each window, we
use the natural language processing method described in Leopold
and Kindermann [67]. A protein subsequence of length l can be
treated as a document, which is a vector containing twenty types of
words, corresponding to amino acids. First, we calculate the
frequencies of the amino acids in each document in the training
data. Let the word wk be the kth type of amino acid. In addition,
let k=1, 2 … 20, fw k,dtrain
i
  
be the frequency of wk in document
i; and let fw k ðÞ denote the frequency of wk in all N documents in
the training data, i.e., fw k ðÞ ~
PN
i~1 fw k,dtrain
i
  
. Second, we
calculate the importance weights of the amino acids, denoted by
r~ r1,r2,   ,r20 ðÞ in all the documents in the training data by the
equation rk~logNz
PN
i~1
fw k,dtrain
i ðÞ
fw k ðÞ log
fw k,dtrain
i ðÞ
fw k ðÞ ,k~1,2,   ,20.
The amino acid composition feature is given by the component-wise
product of fw k,dtest
i
  
and r, and then normalized by the L2 norm.
A feature value close to 1 means the corresponding residue is
more hydrophobic and more amphiphilic, is positively charged,
and has a larger volume and a higher polarity. In the first classifier,
we fill 0.5 as features for nonexistent residues in windows centered
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except charge and volume, we fill zero.
SVMSignal displays the feature profiles on the web service.
Figure 2 shows an example of feature profiles. The green curve
denotes the free energy, the red dots are charge indices; the gray
curve represents the polarity; the blue dotted curve indicates the
residue volumes; the orange curve represents the amphiphilicity;
the blue vertical lines are predicted potential cleavage sites; and the
red vertical line is the predicted cleavage site after post-processing.
The visualization of biochemical feature profiles helps users
recognize signal peptide structures. This example shows a clear
signal peptide structure, which is given by the charged residues
followed by the hydrophobic core and then by the c-region
containing the small neutral and polar residues. Furthermore,
there are several potential cleavage sites after the hydrophobic
core, but only one of them lies near more polar and small residues.
Novel profile pattern features used to capture the
relationship between two biochemical profiles
Given any two of the above five biochemical features, we can
define a nonlinear profile pattern feature to capture the
relationship between two profiles by determining the distance of
a shift between the profiles’ peaks. For example, to model the
signal peptide structure of charged residues in the n-region
followed by the hydrophobic residues in the h-region, we shift the
charge profile by some amino acids (i.e., distance) and compute
the dot product of the free energy profile and the shifted charge
profile. A larger dot product implies a better match between the
profile peaks, and the shift distance determines the sequential
relationship. If maximizing the above dot product yields a positive
shift, it implies that the charged residues are followed by a
hydrophobic core.
Specifically, let f be a vector corresponding to a feature profile,
where f(i) is the feature value of the ith residue for i=1,2,…,100;
and f(i) is 0 otherwise. Similarly, let g be a vector corresponding to
another feature profile. We determine the best shift S1 by the
maximum dot product derived by Equation (1). To capture a
profile’s skewness near the beginning and end positions, i.e.,
positions 1 and 100, we reverse the profile g and then find the best
shift S2, as shown in Equation (2).
S1~argmax
s
X 100
i
fi ðÞ :gi {s ðÞ ,s~{ 99,{98,   0,   98,99 fg ð1Þ
S2~argmax
s
X 100
i
fi ðÞ :gs {i ðÞ ,s~{ 99,{98,   0,   98,99 fg ð2Þ
Figure 1. The hierarchical architecture of SVMSignal.
doi:10.1371/journal.pone.0035018.g001
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extracted from the f and g profiles by simply using the range of
possible shifts, i.e., normalized S1~ S1z100 ðÞ =199. In this way,
we calculate twenty nonlinear pattern features for all permutations
of the five biochemical profiles.
Post-processing to determine cleavage sites
Potential cleavage sites are determined according to the residues
predicted with ‘‘C’’ labels by the first classifier. Since the first
classifier performs residue-wise prediction, the residues labeled
with ‘‘C’’ may occur sparsely anywhere in the query. First, we
identify the ten-residue region nearest the N-terminus that
contains the most ‘‘C’’ labels. We consider ten-residue regions
because we defined five residues around the cleavage site as
positive data. Next, we determine the position of the last residue in
the signal peptide from the residues with ‘‘C’’ labels in the region
that minimizes the total distance between the positions of all ‘‘C’’
labels.
Training the SVM predictors
As the first predictor of SVMSignal is residue-wise and needs to
handle a large number of unstable training samples, we use
DTSVM [68] to train the first classifier. In the training stage, for
each sequence containing a signal peptide, we label the five
residues before and after the cleavage site, a total of 10 residues, as
‘‘C’’ for positive data and ‘‘L’’ for negative data because residues
near the cleavage site may have similar biochemical properties.
DTSVM requires both training and validation sets, so we divide
the Phobius 2004 dataset [16] (described later) into 80% for
training, 10% for validation, and 10% for cross-validation. The
second classifier is a chain-wise predictor and contains 2654
protein chains for training. Because the sample size is not large, we
use LIBSVM [69] with an RBF kernel function to train the model
directly. Then, we integrate the two classifiers to perform 10-fold
cross-validation on the Phobius dataset to determine the
parameters ‘‘cost’’ (2
1.5=2.8284) and ‘‘gamma’’ (2
24.5=0.0442)
in the kernel function of LIBSVM.
Training dataset
To avoid over-estimating our predictor’s performance, we use
the Phobius dataset [16] to train SVMSignal. The dataset contains
247 transmembrane protein sequences, 45 transmembrane protein
sequences with signal peptides, 1,275 sequences containing signal
peptides without transmembrane domains and 1,087 protein
sequences that do not have signal or transmembrane domains.
Benchmark datasets
SPdb dataset. We downloaded SPdb (release 5.1) [19], a
signal peptide database containing signal sequences of archaea,
bacteria, viruses and eukaryotes with all the sequences derived
from Swiss-Prot (release 55.0 2008). Then, taking all 2,512
experimentally verified signal peptide sequences in the dataset, we
used CD-HIT [33] to filter out sequences whose first 100 residues
shared at least 30% sequence similarity with sequences in the
Phobius training dataset. The process produced a dataset of 656
sequences, which we call the SPDB dataset.
UniProt/Swiss-Prot and PDBTM datasets. To evaluate
the predictors’ ability to distinguish signal sequences from non-
signal sequences, we compiled a dataset from UniProt/Swiss-Prot
(downloaded in December 2010) and PDBTM [21] (downloaded
on November 5, 2010). We divided the dataset into three disjoint
groups, i.e., sequences containing signal peptides (denoted by SP),
sequences containing only transmembrane domains (denoted by
TM), and sequences that did not contain transmembrane
domains or signal peptides (denoted by G). The SP dataset was
obtained by querying signal peptides in UniProt/Swiss-Prot with
the evidence code ‘‘experiment’’ or ‘‘probable’’. Note that the SP
dataset includes some signal peptides with ‘‘Transmembrane
[KW-0812]’’ or ‘‘Membrane [KW-0472]’’ annotations. The TM
dataset was obtained by querying ‘‘Transmembrane’’ annotated
with ‘‘experiment’’ or ‘‘probable’’ evidence codes in UniProt/
Swiss-Prot and removing any data with the signal peptide
annotation in any evidence code. We further enlarged the TM
dataset by extracting sequences in PDBTM with structures solved
by X-rays with a resolution less than 4.0 A ˚. The G dataset
contained sequences without signal peptides or TM annotations.
Finally, for each dataset we filtered out sequences whose first 100
residues share at least 30% similarity with sequences in the
Phobius training dataset by using CD-HIT. The resulting SP,
TM, and G datasets contained 901, 104, and 5,755 sequences,
respectively.
Supporting Information
Text S1 The alignments of unique proteins and their
homologous proteins.
(TXT)
Figure 2. An example, O95994 (AGR2_HUMAN), of biochemical feature profiles in a 100-residue N-terminal subsequence predicted
to contain a signal peptide.
doi:10.1371/journal.pone.0035018.g002
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